Imaging of gastrointestinal stromal tumors;Imagerie des tumeurs stromales digestives

Journal de Radiologie

Volumn 90, Issue 4, 2009, Pages 469-480

  Bensimhon, D ^a   Soyer, P ^a   Boudiaf, M ^a   Fargeaudou, Y ^a   Nemeth, J ^a   Pocard, M ^a   Idy Peretti, I ^a   Dray, X ^a   Martin Grivaud, S ^a   Duchat, F ^a   Hamzi, L ^a   Rymer, R ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Computed tomography, CT; Diagnostic Imaging; Gastrointestinal stromal tumors; GIST; Magnetic Resonance Imaging, MRI; Positron emission tomography

Indexed keywords

ENEMA; FLUORODEOXYGLUCOSE; IMATINIB; ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; GASTROINTESTINAL STROMAL TUMOR; HUMAN; LIVER METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIODENSITOMETRY; REVIEW; ADULT; AGED; ARTICLE; BIOPSY; CAPSULE ENDOSCOPY; DIFFERENTIAL DIAGNOSIS; ENDOSCOPIC ECHOGRAPHY; FEMALE; FOLLOW UP; LIVER; LIVER TUMOR; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; RECURRENT DISEASE; SCINTISCANNING; TREATMENT OUTCOME;

ADULT; AGED; ANGIOGRAPHY; ANTINEOPLASTIC AGENTS; BIOPSY; CAPSULE ENDOSCOPY; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; ENDOSONOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL STROMAL TUMORS; HUMANS; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; PYRIMIDINES; RECURRENCE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 67649779615     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0221-0363(09)74006-5     Document Type: Review

References (39)

1. Velasco S, Milin S, Maurel C, et al. Aspects tomodensitométriques des tumeurs stromales gastro-intestinales. Gastroenterol Clin Biol 2008;32:1001-13.
2. Le Cesne A, Landi B, Bonvalot S et al. Recommandations pour la prise en charge des tumeurs stromales gastro intestinales. Ann Pathol 2006;26:231-4.
3. Cassier PA, Dufresne A, Arifi S, et al. Novel approaches to gastrointestinal stromal tumors resistant to imatinib and sunitinib. Curr Gastroenterol Rep 2008;10:555-61.
4. Van den Abbeele AD. The lessons of GIST-PET and PET/CT: a new paradigm for imaging. Oncologist 2008;13:8-13.
5. Hong X, Choi H, Loyer EM, Benjamin RS, Trent JC, Charnsangavej C. Gastrointestinal stromal tumor: role of CT in diagnosis and in response evaluation and surveillance after treatment with imatinib. Radiographics 2006;26:481-95.
6. Bensimhon D, Soyer P, Brouland JP et al. Tumeurs stromales digestives : rôle de la tomodensitométrie avant et après traitement. Gastroenterol Clin Biol 2008;32:91-7.
7. Boudiaf M, Jaff A, Soyer P, Bouhnik Y, et al. Small-bowel diseases: prospective evaluation of multi-detector row helical CT enteroclysis in 107 consecutive patients. Radiology 2004;233:338-44.
8. Kermarrec E, Barbary C, Corby S, et al. L'entéroscanner : revue iconographique. J Radiol 2007;88:235-50.
9. Soyer P, Boudiaf M, Fargeaudou Y, et al. Celiac disease in adults : evaluation with MDCT enteroclysis. AJR Am J Roentgenol 2008;191:1483-92.
10. Sandrasegaran K, Rajesh A, Rushing DA, Rydberg J, Akisik FM, Henley JD. Gastrointestinal stromal tumors: CT and MRI findings. Eur Radiol 2005;15:1407-14.
11. Aubé C, Ridereau-Zins C, Croquet V, Pessaux P. Imagerie en coupes de l'estomac et du duodénum. J Radiol 2004;85:503-14.
12. Tateishi U, Hasegawa T, Satake M, Moriyama N. Gastrointestinal stromal tumor: correlation of computed tomography findings with tumor grade and mortality. J Comput Assist Tomogr 2003; 27:792-8.
13. Ghanem N, Altehoefer C, Furtwangler A, et al. Computed tomography in gastrointestinal stromal tumors. Eur Radiol 2003;13:1669-78.
14. Karila-Cohen P, Petit T, Teissier J, Merran S. Tumeur stromale digestive. J Radiol 2004;85:1911-4.
15. Levy AD, Remotti HE, Thompson WM, Sobin LH, Miettinen M. Gastrointestinal stromal tumors: radiologic features with pathologic correlation. Radiographics 2003;23:283-304.
16. Rousset P, Hoeffel C. Tumeurs du rectum : aspects IRM et scanner. J Radiol 2007;88:1679-87.
17. Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J. Esophageal stromal tumors: a clinicopathologic, immunohisto-chemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol 2000;24:211-22.
18. Sandrasegaran K, Rajesh A, Rydberg J, Rushing DA, Akisik FM, Henley JD. Gastrointestinal stromal tumors: clinical, radiologic, and pathologic features. AJR Am J Roentgenol 2005;184:803-11.
19. Gollub MJ. Imaging of gastrointestinal lymphoma. Radiol Clin North Am 2008; 46:287-312, ix.
20. Scarsbrook AF, Ganeshan A, Statham J. Anatomic and functional imaging of me-tastatic carcinoid tumors. Radiographics 2007;27:455-77.
21. Bechtold RE, Chen MY, Stanton CA, Savage PD, Levine EA. Cystic changes in hepatic and peritoneal metastases from gastrointestinal stromal tumors treated with Gleevec. Abdom Imaging 2003;28:808-14.
22. Choi H, Charnsangavej C, de Castro Faria S, et al. CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. AJR Am J Roentgenol 2004;183:1619-28.
23. Benjamin RS, Choi H, Macapinlac HA, et al. We should desist using RECIST, at least in GIST. J Clin Oncol 2007;25:1760-4.
24. Choi H, Charnsangavej C, Faria SC, et al. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 2007;25: 1753-9.
25. Shankar S, vanSonnenberg E, Desai J, et al. Gastrointestinal stromal tumor: new nodule-within-a-mass pattern of recurrence after partial response to imatinib mesylate. Radiology 2005;235:892-8.
26. Suzuki C, Jacobsson H, Hatschek T, et al. Radiologic measurements of tumor response to treatment: practical approaches and limitations. Radiographics 2008;28:329-44.
27. Malagò R, Manfredi R, Benini L, D'Al-paos G, Pozzi-Mucelli R. Assessment of Crohn's disease activity in the small bowel with MR-enteroclysis: clinico-radiological correlations. Abdom Imaging 2008;33:669-75.
28. Gourtsoyiannis NC, Grammatikakis J, Papamastorakis G, et al. Imaging of small intestinal Crohn's disease: comparison between MR enteroclysis and conventional enteroclysis. Eur Radiol 2006;16:1915-25.
29. Stroszczynski C, Jost D, Reichardt P, et al. Follow-up of gastro-intestinal stromal tumours (GIST) during treatment with imatinib mesylate by abdominal MRI. Eur Radiol 2005;15:2448-56.
30. Alberini JL, Al Nakib M, Wartski M, et al. Place de l'imagerie par tomographie par émission de positons pour les tumeurs stromales gastro-intestinales. Gastroenterol Clin Biol 2007;31:585-93.
31. Kamiyama Y, Aihara R, Nakabayashi T, et al. 18F-fluorodeoxyglucose positron emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors. World J Surg 2005;29:1429-35.
32. Young H, Baum R, Cremerius U, et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer 1999;35:1773-82.
33. Choi H. Response evaluation of gastrointestinal stromal tumors. Oncologist 2008; 13:4-7.
34. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-16.
35. Stroobants S, Goeminne J, Seegers M, et al. 18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). Eur J Cancer 2003;39:2012-20.
36. Lassau N, Lamuraglia M, Chami L, et al. Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography. AJR Am J Roentgenol 2006;187:1267-73.
37. Fang SH, Dong DJ, Zhang SZ, Jin M. Angiographic findings of gastrointestinal stromal tumor. World J Gastroenterol 2004;10:2905-7.
38. Yoon W, Jeong YY, Shin SS, Lim HS, Song SG, Jang NG, Kim JK, Kang HK. Acute massive gastrointestinal bleeding: detection and localization with arterial phase multi-detector row helical CT. Radiology 2006;239:160-7.
39. Blay JY, Landi B, Bonvalot S, et al. Recommandations pour la prise en charge des tumeurs stromales gastro-intestinales (GIST). Bull Cancer 2005;92:907-9.